Cargando…
Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus
BACKGROUND: It is still unclear whether low high-density lipoprotein cholesterol (HDL-C) affects cardiovascular outcomes after acute myocardial infarction (AMI), especially in patients with diabetes mellitus. METHODS: A total of 984 AMI patients with diabetes mellitus from the DIabetic Acute Myocard...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116186/ https://www.ncbi.nlm.nih.gov/pubmed/27863493 http://dx.doi.org/10.1186/s12944-016-0374-5 |
_version_ | 1782468631394779136 |
---|---|
author | Joo, Hyung Joon Cho, Sang-A Hong, Soon Jun Hur, Seung-Ho Bae, Jang-Ho Choi, Dong-Ju Ahn, Young-Keun Park, Jong-Seon Choi, Rak-Kyeong Choi, Donghoon Kim, Joon-Hong Han, Kyoo-Rok Park, Hun-Sik Choi, So-Yeon Yoon, Jung-Han Kwon, Hyeon-Cheol Rha, Seung-Woon Hwang, Kyung-Kuk Jung, Kyung-Tae Oh, Seok-Kyu Lee, Jae-Hwan Shin, Eun-Seok Kim, Kee-Sik Kim, Hyo-Soo Lim, Do-Sun |
author_facet | Joo, Hyung Joon Cho, Sang-A Hong, Soon Jun Hur, Seung-Ho Bae, Jang-Ho Choi, Dong-Ju Ahn, Young-Keun Park, Jong-Seon Choi, Rak-Kyeong Choi, Donghoon Kim, Joon-Hong Han, Kyoo-Rok Park, Hun-Sik Choi, So-Yeon Yoon, Jung-Han Kwon, Hyeon-Cheol Rha, Seung-Woon Hwang, Kyung-Kuk Jung, Kyung-Tae Oh, Seok-Kyu Lee, Jae-Hwan Shin, Eun-Seok Kim, Kee-Sik Kim, Hyo-Soo Lim, Do-Sun |
author_sort | Joo, Hyung Joon |
collection | PubMed |
description | BACKGROUND: It is still unclear whether low high-density lipoprotein cholesterol (HDL-C) affects cardiovascular outcomes after acute myocardial infarction (AMI), especially in patients with diabetes mellitus. METHODS: A total of 984 AMI patients with diabetes mellitus from the DIabetic Acute Myocardial InfarctiON Disease (DIAMOND) Korean multicenter registry were divided into two groups based on HDL-C level on admission: normal HDL-C group (HDL-C ≥ 40 mg/dL, n = 519) and low HDL-C group (HDL-C < 40 mg/dL, n = 465). The primary endpoint was 2-year major adverse cardiovascular events (MACE), defined as a composite of cardiac death, non-fatal myocardial infarction (MI), and target vessel revascularization (TVR). RESULTS: The median follow-up duration was 730 days. The 2-year MACE rates were significantly higher in the low HDL-C group than in the normal HDL-C group (MACE, 7.44% vs. 3.49%, p = 0.006; cardiac death, 3.72% vs. 0.97%, p = 0.004; non-fatal MI, 1.75% vs. 1.55%, p = 0.806; TVR, 3.50% vs. 0.97%, p = 0.007). Kaplan-Meier analysis revealed that the low HDL-C group had a significantly higher incidence of MACE compared to the normal HDL-C group (log-rank p = 0.013). After adjusting for conventional risk factors, Cox proportional hazards analysis suggested that low HDL-C was an independent risk predictor for MACE (hazard ratio [HR] 3.075, 95% confidence interval [CI] 1.034-9.144, p = 0.043). CONCLUSIONS: In patients with diabetes mellitus, low HDL-C remained an independent risk predictor for MACE after adjusting for multiple risk factors during 2-year follow-up of AMI. TRIAL REGISTRATION: This study was the sub-analysis of the prospective multi-center registry of DIAMOND (Diabetic acute myocardial infarction Disease) in Korea. This is the observational study supported by Bayer HealthCare, Korea. Study number is 15614. First patient first visit was 02 April 2010 and last patient last visit was 09 December 2013. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12944-016-0374-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5116186 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-51161862016-11-25 Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus Joo, Hyung Joon Cho, Sang-A Hong, Soon Jun Hur, Seung-Ho Bae, Jang-Ho Choi, Dong-Ju Ahn, Young-Keun Park, Jong-Seon Choi, Rak-Kyeong Choi, Donghoon Kim, Joon-Hong Han, Kyoo-Rok Park, Hun-Sik Choi, So-Yeon Yoon, Jung-Han Kwon, Hyeon-Cheol Rha, Seung-Woon Hwang, Kyung-Kuk Jung, Kyung-Tae Oh, Seok-Kyu Lee, Jae-Hwan Shin, Eun-Seok Kim, Kee-Sik Kim, Hyo-Soo Lim, Do-Sun Lipids Health Dis Research BACKGROUND: It is still unclear whether low high-density lipoprotein cholesterol (HDL-C) affects cardiovascular outcomes after acute myocardial infarction (AMI), especially in patients with diabetes mellitus. METHODS: A total of 984 AMI patients with diabetes mellitus from the DIabetic Acute Myocardial InfarctiON Disease (DIAMOND) Korean multicenter registry were divided into two groups based on HDL-C level on admission: normal HDL-C group (HDL-C ≥ 40 mg/dL, n = 519) and low HDL-C group (HDL-C < 40 mg/dL, n = 465). The primary endpoint was 2-year major adverse cardiovascular events (MACE), defined as a composite of cardiac death, non-fatal myocardial infarction (MI), and target vessel revascularization (TVR). RESULTS: The median follow-up duration was 730 days. The 2-year MACE rates were significantly higher in the low HDL-C group than in the normal HDL-C group (MACE, 7.44% vs. 3.49%, p = 0.006; cardiac death, 3.72% vs. 0.97%, p = 0.004; non-fatal MI, 1.75% vs. 1.55%, p = 0.806; TVR, 3.50% vs. 0.97%, p = 0.007). Kaplan-Meier analysis revealed that the low HDL-C group had a significantly higher incidence of MACE compared to the normal HDL-C group (log-rank p = 0.013). After adjusting for conventional risk factors, Cox proportional hazards analysis suggested that low HDL-C was an independent risk predictor for MACE (hazard ratio [HR] 3.075, 95% confidence interval [CI] 1.034-9.144, p = 0.043). CONCLUSIONS: In patients with diabetes mellitus, low HDL-C remained an independent risk predictor for MACE after adjusting for multiple risk factors during 2-year follow-up of AMI. TRIAL REGISTRATION: This study was the sub-analysis of the prospective multi-center registry of DIAMOND (Diabetic acute myocardial infarction Disease) in Korea. This is the observational study supported by Bayer HealthCare, Korea. Study number is 15614. First patient first visit was 02 April 2010 and last patient last visit was 09 December 2013. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12944-016-0374-5) contains supplementary material, which is available to authorized users. BioMed Central 2016-11-18 /pmc/articles/PMC5116186/ /pubmed/27863493 http://dx.doi.org/10.1186/s12944-016-0374-5 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Joo, Hyung Joon Cho, Sang-A Hong, Soon Jun Hur, Seung-Ho Bae, Jang-Ho Choi, Dong-Ju Ahn, Young-Keun Park, Jong-Seon Choi, Rak-Kyeong Choi, Donghoon Kim, Joon-Hong Han, Kyoo-Rok Park, Hun-Sik Choi, So-Yeon Yoon, Jung-Han Kwon, Hyeon-Cheol Rha, Seung-Woon Hwang, Kyung-Kuk Jung, Kyung-Tae Oh, Seok-Kyu Lee, Jae-Hwan Shin, Eun-Seok Kim, Kee-Sik Kim, Hyo-Soo Lim, Do-Sun Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus |
title | Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus |
title_full | Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus |
title_fullStr | Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus |
title_full_unstemmed | Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus |
title_short | Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus |
title_sort | impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116186/ https://www.ncbi.nlm.nih.gov/pubmed/27863493 http://dx.doi.org/10.1186/s12944-016-0374-5 |
work_keys_str_mv | AT joohyungjoon impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT chosanga impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT hongsoonjun impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT hurseungho impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT baejangho impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT choidongju impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT ahnyoungkeun impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT parkjongseon impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT choirakkyeong impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT choidonghoon impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT kimjoonhong impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT hankyoorok impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT parkhunsik impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT choisoyeon impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT yoonjunghan impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT kwonhyeoncheol impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT rhaseungwoon impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT hwangkyungkuk impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT jungkyungtae impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT ohseokkyu impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT leejaehwan impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT shineunseok impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT kimkeesik impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT kimhyosoo impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus AT limdosun impactoflowhighdensitylipoproteincholesterollevelon2yearclinicaloutcomesafteracutemyocardialinfarctioninpatientswithdiabetesmellitus |